KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Proteus mirabilis (W229)

• Proteus mirabilis
• Proteus mirabilis (08103)
• Proteus mirabilis (1287)
• Proteus mirabilis (304)
• Proteus mirabilis (33)
• Proteus mirabilis (3750 + β-lactamase positive)
• Proteus mirabilis (48575)
• Proteus mirabilis (ATCC 14153)
• Proteus mirabilis (ATCC 25933)
• Proteus mirabilis (ATCC 29245)
• Proteus mirabilis (ATCC 7002)
• Proteus mirabilis (ATCC 9240 + CAMHB + pH 5.8)
• Proteus mirabilis (ATCC 9240 + CAMHB + pH 7.2)
• Proteus mirabilis (C889)
• Proteus mirabilis (ESBL)
• Proteus mirabilis (IFO 12255)
• Proteus mirabilis (IFO 3849)
• Proteus mirabilis (MB)
• Proteus mirabilis (nalidixic acid-resistant)
• Proteus mirabilis (nalidixic acid-susceptible)
• Proteus mirabilis (NCIM 2300)
• Proteus mirabilis (NCTC 60)
• Proteus mirabilis (OBT 505)
• Proteus mirabilis (ofloxacin-susceptible)
• Proteus mirabilis (polymyxin B-resistant)
• Proteus mirabilis (tetracycline-resistant)
• Proteus mirabilis (tetracycline-susceptible)
• Proteus mirabilis (W229)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8